CTCs are cancer cells that shed from primary or metastatic tumors and enter the bloodstream. These cells circulate through the blood, travel to distant organs and tissues, and may form new tumors, leading to cancer metastasis.
Detectable Cancer Types
Detectable Cancer Types
Product Advantages
Sample Collection Process
Sample Collection Process
Data and Significance
CTC 追蹤表
受檢者
循環腫瘤細胞數量
建議
一般健康者
<5
每6個月定期追蹤一次
>5
建議就醫 每3–6個月定期追蹤一次
癌症患者
治療中
<5
每6個月定期追蹤一次
>5
遵照醫師指示進行療程
完成治療
<5
每3–6個月定期追蹤一次
>5
每1–3個月定期追蹤一次
Real-time cancer recurrence monitoring helps understand whether the disease is in remission or worsening.
Upward Trend: Increased risk of cancer recurrence
Downward Trend: Decreased risk of cancer recurrence
Data and Significance
CTC 追蹤表
受檢者
循環腫瘤細胞數量
建議
一般健康者
<5
每6個月定期追蹤一次
>5
建議就醫 每3–6個月定期追蹤一次
癌症患者
治療中
<5
每6個月定期追蹤一次
>5
遵照醫師指示進行療程
完成治療
<5
每3–6個月定期追蹤一次
>5
每1–3個月定期追蹤一次
Real-time cancer recurrence monitoring helps understand whether the disease is in remission or worsening.
Upward Trend: Increased risk of cancer recurrence
Downward Trend: Decreased risk of cancer recurrence
Chiline CATCH® Circulating Tumor Cell Test
Regular Monitoring for Health Protection
Circulating Tumor Cells
(CTCs)
CTCs are cancer cells that shed from primary or metastatic tumors and enter the bloodstream.
Detectable Cancer Types
Product Advantages
Sample Collection Process
Data and Significance
CTC 追蹤表
受檢者
循環腫瘤細胞數量
建議
一般健康者
<5
每6個月定期追蹤一次
>5
建議就醫 每3–6個月定期追蹤一次
癌症患者
治療中
<5
每6個月定期追蹤一次
>5
遵照醫師指示進行療程
完成治療
<5
每3–6個月定期追蹤一次
>5
每1–3個月定期追蹤一次
Real-time cancer recurrence monitoring helps understand whether the disease is in remission or worsening.
Upward Trend: Increased risk of cancer recurrence
Downward Trend: Decreased risk of cancer recurrence